| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.73B | 37.29B | 35.66B | 35.51B | 35.83B | 32.62B |
| Gross Profit | 17.77B | 17.66B | 16.23B | 15.75B | 15.73B | 13.92B |
| EBITDA | 2.42B | 2.56B | 2.57B | 2.22B | 2.24B | -891.63M |
| Net Income | 1.16B | 1.25B | 1.34B | 985.73M | 972.68M | -2.21B |
Balance Sheet | ||||||
| Total Assets | 28.60B | 28.13B | 27.78B | 27.69B | 28.54B | 29.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 1.37B | 1.41B | 1.90B | 2.13B | 1.33B |
| Total Debt | 5.45B | 4.44B | 5.24B | 6.51B | 7.70B | 8.95B |
| Total Liabilities | 12.92B | 12.42B | 13.11B | 14.21B | 15.84B | 17.91B |
| Stockholders Equity | 15.51B | 15.54B | 14.52B | 13.34B | 12.59B | 11.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 993.80M | 938.12M | 1.35B | 2.23B | 989.60M |
| Operating Cash Flow | 0.00 | 1.49B | 1.59B | 1.77B | 2.75B | 1.56B |
| Investing Cash Flow | 0.00 | -492.20M | -583.06M | -561.28M | -443.56M | -711.49M |
| Financing Cash Flow | 0.00 | -1.04B | -1.49B | -1.44B | -1.50B | -875.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥316.97B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
77 Outperform | ¥7.21B | 1.85 | ― | 3.35% | 7.25% | -11.62% | |
77 Outperform | ¥62.75B | 11.67 | 16.91% | 2.28% | 12.37% | 26.48% | |
73 Outperform | ¥103.60B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
73 Outperform | ¥371.74B | 9.25 | ― | 3.13% | 1.50% | 9.82% | |
69 Neutral | ¥468.28B | 14.68 | ― | 3.37% | 4.50% | -9.36% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |